Bitcoin Generation Inc. (BTGN)

[mrpenny2000]

InoLife Technologies Inc. is Today's Focus Stock on MicroStockProfit.com

DALLAS, Sep 2, 2010 (GlobeNewswire via COMTEX) -- MicroStockProfit.com announces
an investment report featuring InoLife Technologies Inc. (INOL). The report
includes financial, comparative and investment analyses, and industry information
you need to know to make an educated investment decision.

The full report is available at: http://www.microstockprofit.com/lp/INOL

InoLife Technologies Inc. (INOL), formerly NexxNow Inc., is a development-stage
company. The Company is a service-based healthcare products development,
integration and marketing company, primarily focused upon products, services and
solutions. It operates two lines of businesses both in the medical field. Its
first line of business is the development of veterinary oncological treatments
(cancer in animals). Its second line of business is to provide deoxyribonucleic
acid (DNA) testing for paternity tests and to screen for certain genetic
diseases. It licenses the DNA test kits. The principal users of its products and
services include healthcare providers, including physicians, veterinarians,
hospitals and outpatient facilities, in addition to individuals with a direct
need for the solutions it provides. INOL is organized to address two specific,
but different, markets: the companion animal (dogs and cats) healthcare market
and the human healthcare market.

Message Board Search for INOL: http://www.boardcentral.com/boards/INOL

In the report, the analyst notes:

"The Company realized a net loss of $ 37,563 for the three months ended June 30,
2010. During the period from inception to June 30, 2010, INOL realized an
Accumulated Deficit of $1,130,890, primarily due to a total of $759,590 of Losses
Due to Recapitalization Expenses during the period from inception to June 30,
2010.

"INOL recently announced it will provide and market a proprietary metabolizing
test to physicians and practitioners to identify how a patient's genetic makeup
may affect the body's response to Plavix (colpidogrel)."

To read the entire report visit: http://www.microstockprofit.com/lp/INOL

See what investors are saying about INOL at http://www.stockhideout.com

Get breaking news on INOL at http://thestockmarketwatch.com/

MicroStockProfit.com is a small-cap research and investment commentary provider.
MicroStockProfit.com strives to provide a balanced view of many promising
small-cap companies that would otherwise fall under the radar of the typical Wall
Street investor. We provide investors with an excellent first step in their
research and due diligence by providing daily trading ideas, and consolidating
the public information available on them. For more information on
MicroStockProfit please visit: http://www.microstockprofit.com

MicroStockProfit.com Disclosure

MicroStockProfit.com is not a registered investment advisor and nothing contained
in any materials should be construed as a recommendation to buy or sell any
securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors,
LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest
in the mentioned company; nor have they received compensation of any kind for any
of the companies listed in this communication. Please read our report and visit
our Web site, MicroStockProfit.com, for complete risks and disclosures.

This news release was distributed by GlobeNewswire, http://www.globenewswire.com

SOURCE: MicroStockProfit.com
CONTACT:MicroStockProfit.com
Brian Johnson
1-888-307-2850
[e-mail]


(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.